HNRNPA1 and amyotrophic lateral sclerosis: Indeed, changes of HNRNPA1 and HNRNPA2 expression can improve the condition of patients with amyotrophic lateral sclerosis, spinal muscular atrophy, Alzheimer’s disease, and other neurodegenerative diseases (Bekenstein and Soreq, 2013).